What Actually Helps

Replacing the estrogen your body has stopped making. The most effective treatment for hot flashes, reducing frequency by 75–90%. Available as patches, gels, sprays, or pills.

FDA-approved in 2023. Blocks the specific brain receptor (NK3) that triggers hot flashes without affecting estrogen. A non-hormonal option with strong clinical trial evidence.

Paroxetine (Brisdelle) was the first FDA-approved non-hormonal prescription option specifically for hot flashes (2013). Other SSRIs and SNRIs (venlafaxine, escitalopram) are effective off-label. Reduces hot flash frequency by ~50%.

Originally an epilepsy medication, gabapentin reduces hot flash frequency, particularly at night. Especially useful if sleep disruption is prominent. Trial data shows benefit but results are more mixed than for fezolinetant or SSRIs.

CBT adapted for menopause teaches women to change their response to hot flashes — reducing their perceived severity and interference with daily life. Strong trial evidence, particularly for quality of life.

Slow, diaphragmatic breathing (6 breaths per minute) during a hot flash can reduce its intensity. Easy to learn, zero side effects.

Estrogen has antidepressant-like effects specifically during perimenopause. Multiple trials show it reduces perimenopausal depression and mood instability. Importantly, this window effect means HRT works better for mood in perimenopause than postmenopause.

Bioidentical progesterone that the body converts to allopregnanolone — the same calming brain chemical that declines in perimenopause. Taken at night, it reduces anxiety and improves sleep.

Standard antidepressants are effective for perimenopausal depression and anxiety, particularly when mood symptoms are severe or when HRT is not appropriate.

CBT and mindfulness-based approaches have strong evidence for perimenopausal depression and anxiety, either alone or combined with medication.

The gold-standard first-line treatment for insomnia — restructures unhelpful sleep behaviours and beliefs. More effective long-term than sleeping pills. Available via therapists, books, or apps.

Taken orally at night, progesterone converts to a GABA-A receptor modulator (similar to a mild sedative). Improves sleep quality and duration.

Improves sleep mainly by reducing night sweats that cause waking. Direct sleep effects beyond this are modest.

Consistent sleep/wake times, cool bedroom, limiting screens before bed. Aerobic exercise improves sleep quality in perimenopausal women.

Applied locally to the vaginal tissue, estrogen restores thickness, lubrication, and normal pH. Systemic absorption is minimal — this is considered safe even for many women who cannot take systemic HRT. The most effective treatment for GSM.

A precursor hormone applied vaginally that the tissue converts locally to both estrogen and testosterone. FDA-approved for painful sex due to menopause.

An oral tablet (SERM) that acts like estrogen in vaginal tissue without being an estrogen. Good option for women who prefer oral treatment or cannot use vaginal products.

Non-hormonal vaginal moisturisers (used regularly) and lubricants (used during sex) help manage symptoms but don't restore tissue health. Best used alongside other treatments.

Estrogen directly prevents bone loss and has anti-inflammatory effects that reduce joint pain. Starting HRT during perimenopause can prevent the most significant period of bone loss.

Medications that slow bone breakdown. Used when bone density is already low or HRT is not appropriate. Weekly or monthly tablets, or annual infusions.

Vitamin D is essential for calcium absorption and bone health. Deficiency (extremely common) accelerates bone loss. D3 form is preferred. Get levels tested first.

Weight-bearing and resistance exercise is the only non-pharmacological approach with strong evidence for building and maintaining bone. Also reduces joint pain and improves muscle mass.

Hypothyroidism and deficiencies in B12, folate, ferritin, and vitamin D all cause identical cognitive symptoms and are easily missed on standard panels. Always check these before attributing brain fog to hormones.

Poor sleep is one of the biggest drivers of cognitive symptoms. Treating sleep independently often significantly improves cognitive complaints.

Observational data (SWAN, Cache County studies) suggest that estrogen started during perimenopause may preserve cognitive function. There are no large RCTs specifically on this. The "timing hypothesis" applies here too.

Aerobic exercise, resistance training, Mediterranean-style diet, and not smoking all reduce cardiovascular risk. The transition is a critical window to establish these habits.

The "timing hypothesis": HRT started in perimenopause or within 10 years of menopause (before age 60) appears cardioprotective in observational data (Nurses' Health Study reported ~50% lower CHD risk). Smaller RCTs (KEEPS, ELITE) show favourable trends but have not confirmed the magnitude of benefit. HRT started late (>10 years postmenopause) does not show this benefit.

If LDL or ApoB is elevated, statin therapy has clear cardiovascular benefit regardless of menopausal status.

Resistance training preserves muscle mass that declines with estrogen loss. Muscle burns more energy at rest, directly countering the metabolic slowdown. Both aerobic and strength work improve insulin sensitivity.

HRT can attenuate the shift to visceral fat distribution and improve insulin sensitivity. It does not cause weight loss, but may prevent the weight gain pattern specific to menopause.

Higher protein intake preserves muscle. Dietary fibre supports gut microbiome health and estrogen recirculation (via the estrobolome). Mediterranean-style diet has the best evidence overall.